These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23115063)
1. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063 [TBL] [Abstract][Full Text] [Related]
2. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021 [TBL] [Abstract][Full Text] [Related]
3. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of glioma and meta-analysis. Rajaraman P; Melin BS; Wang Z; McKean-Cowdin R; Michaud DS; Wang SS; Bondy M; Houlston R; Jenkins RB; Wrensch M; Yeager M; Ahlbom A; Albanes D; Andersson U; Freeman LE; Buring JE; Butler MA; Braganza M; Carreon T; Feychting M; Fleming SJ; Gapstur SM; Gaziano JM; Giles GG; Hallmans G; Henriksson R; Hoffman-Bolton J; Inskip PD; Johansen C; Kitahara CM; Lathrop M; Liu C; Le Marchand L; Linet MS; Lonn S; Peters U; Purdue MP; Rothman N; Ruder AM; Sanson M; Sesso HD; Severi G; Shu XO; Simon M; Stampfer M; Stevens VL; Visvanathan K; White E; Wolk A; Zeleniuch-Jacquotte A; Zheng W; Decker P; Enciso-Mora V; Fridley B; Gao YT; Kosel M; Lachance DH; Lau C; Rice T; Swerdlow A; Wiemels JL; Wiencke JK; Shete S; Xiang YB; Xiao Y; Hoover RN; Fraumeni JF; Chatterjee N; Hartge P; Chanock SJ Hum Genet; 2012 Dec; 131(12):1877-88. PubMed ID: 22886559 [TBL] [Abstract][Full Text] [Related]
5. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Chen H; Chen Y; Zhao Y; Fan W; Zhou K; Liu Y; Zhou L; Mao Y; Wei Q; Xu J; Lu D Am J Epidemiol; 2011 Apr; 173(8):915-22. PubMed ID: 21350045 [TBL] [Abstract][Full Text] [Related]
6. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility. Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245 [TBL] [Abstract][Full Text] [Related]
8. Interaction between 5 genetic variants and allergy in glioma risk. Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933 [TBL] [Abstract][Full Text] [Related]
9. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants. Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493 [TBL] [Abstract][Full Text] [Related]
10. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Wrensch M; Jenkins RB; Chang JS; Yeh RF; Xiao Y; Decker PA; Ballman KV; Berger M; Buckner JC; Chang S; Giannini C; Halder C; Kollmeyer TM; Kosel ML; LaChance DH; McCoy L; O'Neill BP; Patoka J; Pico AR; Prados M; Quesenberry C; Rice T; Rynearson AL; Smirnov I; Tihan T; Wiemels J; Yang P; Wiencke JK Nat Genet; 2009 Aug; 41(8):905-8. PubMed ID: 19578366 [TBL] [Abstract][Full Text] [Related]
11. RTEL1 tagging SNPs and haplotypes were associated with glioma development. Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922 [TBL] [Abstract][Full Text] [Related]
12. Joint associations between genetic variants and reproductive factors in glioma risk among women. Wang SS; Hartge P; Yeager M; Carreón T; Ruder AM; Linet M; Inskip PD; Black A; Hsing AW; Alavanja M; Beane-Freeman L; Safaiean M; Chanock SJ; Rajaraman P Am J Epidemiol; 2011 Oct; 174(8):901-8. PubMed ID: 21920947 [TBL] [Abstract][Full Text] [Related]
13. Genetic risk profiles identify different molecular etiologies for glioma. Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058 [TBL] [Abstract][Full Text] [Related]
14. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population. Song X; Zhou K; Zhao Y; Huai C; Zhao Y; Yu H; Chen Y; Chen G; Chen H; Fan W; Mao Y; Lu D Carcinogenesis; 2012 May; 33(5):1065-71. PubMed ID: 22387365 [TBL] [Abstract][Full Text] [Related]
15. Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population. Namgoong S; Cheong HS; Kim JH; Kim LH; Seo JY; Kang SG; Yoon SJ; Kim SH; Chang JH; Shin HD PLoS One; 2018; 13(11):e0207660. PubMed ID: 30462709 [TBL] [Abstract][Full Text] [Related]
16. Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants. Wu Y; Tong X; Tang LL; Zhou K; Zhong CH; Jiang S Asian Pac J Cancer Prev; 2014; 15(17):7163-7. PubMed ID: 25227808 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide association study identifies five susceptibility loci for glioma. Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367 [TBL] [Abstract][Full Text] [Related]
18. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies. Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444 [TBL] [Abstract][Full Text] [Related]
19. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Di Stefano AL; Enciso-Mora V; Marie Y; Desestret V; Labussière M; Boisselier B; Mokhtari K; Idbaih A; Hoang-Xuan K; Delattre JY; Houlston RS; Sanson M Neuro Oncol; 2013 May; 15(5):542-7. PubMed ID: 23161787 [TBL] [Abstract][Full Text] [Related]
20. RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population. Jin TB; Zhang JY; Li G; Du SL; Geng TT; Gao J; Liu QP; Gao GD; Kang LL; Chen C; Li SQ Tumour Biol; 2013 Dec; 34(6):3659-66. PubMed ID: 23812731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]